From: Characterizing patients with rare mucormycosis infections using real-world data
Group selection steps | Patients | % of total patients | % of patients in step 2 (1) |
---|---|---|---|
1. All the patients enrolled during Jan 2007–Jun 2019 in Optum® | 101,340,454 | 100.00 | – |
2. (1) and with HM and 6 months follow-up | 962,428 | 0.95 | 100.00 |
3. (2) and with IA between index and enrollment end date | 10,638 | 0.01 | 1.11 |
4. (2) and with IM between index and enrollment end date | 1133 | 0.00 | 0.12 |
5. (2) and coinfected with IA and IM within 360 days post-index | 161 | 0.00 | 0.02 |